HQYHealthEquity, Inc.
Price
-1.2%1YEnd-of-day closes, not the intraday tick.
A rare clean sweep: double-check what the checks can't see
Quality strong, no red flags, undemanding price, growing in the filings, the market undecided.
We are a leader and an innovator in providing technology-enabled services that empower consumers to make healthcare saving, spending, and investing decisions. We use our innovative technology to manage consumers' tax-advantaged health savings accounts (“HSAs”) and other consumer-directed benefits (“CDBs”) offered by employers, including flexible spending accounts and health reimbursement arrangements (“FSAs” and “HRAs”), and to administer Consolidated Omnibus Budget Reconciliation Act (“COBRA”), commuter and other benefits.
In the company’s own words · 10-K filed Mar 17, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
HealthEquity, Inc. (HQY) reported revenue of $351M in Q2 2027 (quarter ended Jul 31, 2026), up 7.6% from the same quarter a year earlier. That came with a gross margin of 74% and net income of $66M (19% of revenue). For the full year FY2026, revenue was $1.31B (+9.5% year on year) and net income $215M. Its largest product in Q2 2027 was Financial Service Other at $176M, 50% of the disclosed total, ahead of Service at 35%. The next results filing is expected around Dec 2, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 30, 2026On September 24, 2026, the Board of Directors (the “Board”) of HealthEquity, Inc. (the “Company”) appointed Noémie Heuland as a member of the Board, effective immediately.Director or officer change · Form 8-K
- May 8, 2026On May 5, 2026, each of Scott Cutler (President and Chief Executive Officer), James Lucania (Executive Vice President and Chief Financial Officer), Dr. Stephen Neeleman, M.D. (Founder and Vice Chairman), Michael Fiore (Executive Vice President and Chief Commercial Officer), Sunil Rajasekar (Executive Vice President …Director or officer change · Form 8-K
- Apr 6, 2026On April 6, 2026, HealthEquity, Inc. (the “Company”) announced that the employment of Eli Rosner, the Company’s Chief Technology Officer, will be terminated by the Company without cause, effective April 17, 2026.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Sep 2026 · $350.7MThe company’s own SEC segment disclosure.
- Financial Service Other$175.9M50%
- Service$124.4M35%
- Credit And Debit Card$50.4M14%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Health Information Services
Ranks #7 of 20 by RyuScore